Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
09:23am, Monday, 24'th Jun 2024
ResMed stock and Inspire Medical Systems stock tumbled Monday after Eli Lilly said its weight-loss drug reduced sleep apnea events.
ResMed Stock Is Sinking. Blame Lilly's Zepbound Trials for Sleep Apnea.
07:49am, Monday, 24'th Jun 2024
Eli Lilly is seeking FDA approval to expand the uses for its weight-loss drug Zepbound to include sleep apnea.
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
10:50am, Wednesday, 19'th Jun 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
4 Medical Product Stocks to Buy From a Recovering Industry
08:30am, Wednesday, 19'th Jun 2024
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. BSX, RMD, LNTH and HAE are well-poised to
4 GARP Stocks to Scoop up for Maximum Returns
10:55am, Monday, 10'th Jun 2024
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RMD, BAH, BAP and AXP are some stocks that hold promise.
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
09:05am, Monday, 10'th Jun 2024
SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: RMD) presented 13 new clinical studies at SLEEP 2024, the
Here's Why ResMed (RMD) is a Strong Momentum Stock
10:56am, Thursday, 06'th Jun 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Reasons Growth Investors Will Love ResMed (RMD)
01:45pm, Friday, 31'st May 2024
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why ResMed (RMD) is a Strong Growth Stock
10:46am, Friday, 31'st May 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ResMed (RMD) Up 16.3% Since Last Earnings: Will it Continue?
12:31pm, Monday, 27'th May 2024
Investors are optimistic about ResMed (RMD) led by strong growth in the U.S. mask and accessories business and its cloud-connected platforms.
Scoop up These 4 GARP Stocks to Receive Handsome Returns
11:21am, Friday, 24'th May 2024
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. CSL, RMD, BAH and BAP are some stocks that hold promise.
Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure (PAP) therapy reduced risks of death and hospitalization for patients with obstructive sleep
Wall Street Analysts See ResMed (RMD) as a Buy: Should You Invest?
10:31am, Tuesday, 21'st May 2024
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Here's Why Investors Should Buy ResMed (RMD) Stock Now
11:50am, Monday, 20'th May 2024
Investors are optimistic about ResMed's (RMD) potential in digital health and expansion in the international market.
Boston Scientific (BSX) mCRM System Study Outcome Favorable
12:00am, Monday, 20'th May 2024
Boston Scientific Corporation (BSX Quick QuoteBSX - Free Report) recently presented favorable six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRM System — the first mod
